Prot# CA029: An Open-Label, Phase I/II Trial of ABI-007 (A Cremophor®-Free, Protein Stabilized, Nanoparticle Paclitaxel) Plus Carboplatin and Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/8/0611/20/08

Funding

  • American BioScience, Inc. (CA029)